Form 4 for MRVL Marvell Technology
Accepted 2022-04-19 00:00:00 ET · period of report 2022-04-15 · accession 0000899243-22-015126 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-19 | 2022-04-15 | MRVL | Meintjes Willem A | SVP, CAO | M - OptEx | $0.00 | +30.0K | 90.3K | +50% | $0 |
| DM | 2022-04-19 | 2022-04-15 | MRVL | Meintjes Willem A | SVP, CAO | F - Tax | $60.97 | -12.9K | 79.4K | -14% | -$788.8K |
| D | 2022-04-19 | 2022-04-15 | MRVL | Meintjes Willem A | SVP, CAO | A - Grant | $0.00 | +9,185 | 9,185 | New | $0 |
| DM | 2022-04-19 | 2022-04-15 | MRVL | Meintjes Willem A | SVP, CAO | M - OptEx | $0.00 | -30.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-15 | M | A | 1,134 | $0.00 | 63,431 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-15 | M | A | 1,160 | $0.00 | 79,317 | D | — | — | |
| 3 | Common | Common Stock | 2022-04-15 | F | D | 327 | $60.97 | 78,990 | D | — | — | |
| 4 | Common | Common Stock | 2022-04-15 | F | D | 12,134 | $60.97 | 78,157 | D | — | — | |
| 5 | Common | Common Stock | 2022-04-15 | M | A | 538 | $0.00 | 79,528 | D | — | — | |
| 6 | Common | Common Stock | 2022-04-15 | F | D | 344 | $60.97 | 63,087 | D | — | — | |
| 7 | Common | Common Stock | 2022-04-15 | M | A | 27,204 | $0.00 | 90,291 | D | — | — | |
| 8 | Common | Common Stock | 2022-04-15 | F | D | 132 | $60.97 | 79,396 | D | — | — | |
| 9 | Derivative | Restricted Stock Units | 2022-04-15 | A | A | 9,185 | $0.00 | 9,185 | D | — · — to — | 9,185 Common Stock | (F2) Each RSU represents a contingent right to receive one Marvell common share upon vesting. (F7) The RSUs will vest in equal quarterly installments over three years, and were granted as part of the annual grant process. |
| 10 | Derivative | Restricted Stock Units | 2022-04-15 | M | D | 538 | $0.00 | 4,306 | D | — · — to — | 538 Common Stock | (F2) Each RSU represents a contingent right to receive one Marvell common share upon vesting. (F6) The remaining RSUs will vest on 07/15/2022, 10/15/22, 01/15/2023, 04/15/2023, 07/15/2023, 10/15/2023, 01/15/2024 and 04/15/2024. |
| 11 | Derivative | Restricted Stock Units | 2022-04-15 | M | D | 1,160 | $0.00 | 4,639 | D | — · — to — | 1,160 Common Stock | (F2) Each RSU represents a contingent right to receive one Marvell common share upon vesting. (F5) The remaining RSUs will vest on 07/15/2022, 10/15/22, 01/15/2023 and 04/15/2023. |
| 12 | Derivative | Restricted Stock Units | 2022-04-15 | M | D | 27,204 | $0.00 | 0 | D | — · — to — | 27,204 Common Stock | (F2) Each RSU represents a contingent right to receive one Marvell common share upon vesting. (F4) This grant is fully vested. Reflects the number of shares earned in respect of performance based restricted stock units granted on 04/15/2019. The achievement levels of the relative TSR performance metrics applicable to the award and the number of shares earned based on such results were certified on 04/15/2022. |
| 13 | Derivative | Restricted Stock Units | 2022-04-15 | M | D | 1,134 | $0.00 | 0 | D | — · — to — | 1,134 Common Stock | (F2) Each RSU represents a contingent right to receive one Marvell common share upon vesting. (F3) This award fully vested on April 15, 2022. |